New Zealand markets closed

Intercept Pharmaceuticals, Inc. (ICPT)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
15.38-0.23 (-1.47%)
At close: 04:00PM EST
15.40 +0.02 (+0.13%)
After hours: 05:18PM EST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2020
31/12/2019
31/12/2018
Total revenue
354,332
312,690
252,002
179,804
Cost of revenue
2,853
5,322
4,212
2,519
Gross profit
351,479
307,368
247,790
177,285
Operating expenses
Research development
185,504
191,485
242,799
207,301
Selling general and administrative
240,221
332,493
317,418
255,474
Total operating expenses
425,725
523,978
560,217
462,775
Operating income or loss
-74,246
-216,610
-312,427
-285,490
Interest expense
51,250
48,054
41,144
30,523
Total other income/expenses net
18,309
-10,216
8,890
6,771
Income before tax
-107,293
-274,880
-344,681
-309,242
Income from continuing operations
-107,293
-274,880
-344,681
-309,242
Net income
-107,293
-274,880
-344,681
-309,242
Net income available to common shareholders
-107,293
-274,880
-344,681
-309,242
Basic EPS
-
-8.34
-10.89
-10.86
Diluted EPS
-
-8.34
-10.89
-10.86
Basic average shares
-
32,970
31,654
28,464
Diluted average shares
-
32,970
31,654
28,464
EBITDA
-
-223,708
-299,874
-274,137